60
Participants
Start Date
June 13, 2022
Primary Completion Date
December 31, 2025
Study Completion Date
December 31, 2025
Luteolin
The luteolin target dose will be 300 mg BID taken over 12 weeks in capsule form
Placebo
The placebo target dose will be 300 mg BID taken over 12 weeks in capsule form
COMPLETED
Maryland Psychiatric Research Center, Baltimore
RECRUITING
University of California, Los Angeles, Los Angeles
University of California, Los Angeles
OTHER
Stanley Medical Research Institute
OTHER
University of Maryland, Baltimore
OTHER